Table 2

The ATHENA cohort: participant characteristics of the 19 035 HIV-1-positive people in HIV care by 1 January 2017

Men who have sex with menHeterosexualInjecting drug useBlood or blood productsOther/unknownTotal
MenMenWomenMenWomenMenWomenMenWomenMenWomen
n=11 928n=2377n=3104n=224n=84n=151n=89n=795n=283n=15 475n=3560
Current age in years
 0–120
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
57
7.2%
77
27.2%
57
0.4%
77
2.2%
 13–174
0.0%
0
0.0%
1
0.0%
0
0.0%
0
0.0%
1
0.7%
2
2.2%
43
5.4%
26
9.2%
48
0.3%
29
0.8%
 18–24199
1.7%
16
0.7%
37
1.2%
0
0.0%
0
0.0%
3
2.0%
1
1.1%
46
5.8%
41
14.5%
264
1.7%
79
2.2%
 25–341432
12.0%
221
9.3%
497
16.0%
4
1.8%
2
2.4%
18
11.9%
10
11.2%
87
10.9%
32
11.3%
1762
11.4%
541
15.2%
 35–442547
21.4%
488
20.5%
1017
32.8%
36
16.1%
10
11.9%
24
15.9%
22
24.7%
115
14.5%
38
13.4%
3210
20.7%
1087
30.5%
 45–544131
34.6%
853
35.9%
955
30.8%
92
41.1%
34
40.5%
55
36.4%
29
32.6%
214
26.9%
37
13.1%
5345
34.5%
1055
29.6%
 55–642548
21.4%
538
22.6%
415
13.4%
79
35.3%
34
40.5%
26
17.2%
16
18.0%
142
17.9%
26
9.2%
3333
21.5%
491
13.8%
 65–74929
7.8%
222
9.3%
144
4.6%
13
5.8%
4
4.8%
22
14.6%
6
6.7%
73
9.2%
5
1.8%
1259
8.1%
159
4.5%
 ≥75138
1.2%
39
1.6%
38
1.2%
0
0.0%
0
0.0%
2
1.3%
3
3.4%
18
2.3%
1
0.4%
197
1.3%
42
1.2%
Current age 50 years or older
 No6132
51.4%
1150
48.4%
2085
67.2%
74
33.0%
17
20.2%
69
45.7%
53
59.6%
449
56.5%
232
82.0%
7874
50.9%
2387
67.1%
 Yes5796
48.6%
1227
51.6%
1019
32.8%
150
67.0%
67
79.8%
82
54.3%
36
40.4%
346
43.5%
51
18.0%
7601
49.1%
1173
32.9%
Current age 60 years or older
 No9899
83.0%
1911
80.4%
2776
89.4%
180
80.4%
68
81.0%
117
77.5%
75
84.3%
648
81.5%
267
94.3%
12 755
82.4%
3186
89.5%
 Yes2029
17.0%
466
19.6%
328
10.6%
44
19.6%
16
19.0%
34
22.5%
14
15.7%
147
18.5%
16
5.7%
2720
17.6%
374
10.5%
Region of origin
 Netherlands8669
72.7%
1136
47.8%
913
29.4%
132
58.9%
41
48.8%
97
64.2%
17
19.1%
360
45.3%
102
36.0%
10 394
67.2%
1073
30.1%
 Sub-Saharan Africa164
1.4%
636
26.8%
1304
42.0%
4
1.8%
0
0.0%
29
19.2%
38
42.7%
225
28.3%
105
37.1%
1058
6.8%
1447
40.6%
 Western Europe744
6.2%
80
3.4%
71
2.3%
24
10.7%
27
33.1%
3
2.0%
3
3.4%
31
3.9%
25
8.8%
882
5.7%
126
3.5%
 South America749
6.3%
209
8.8%
307
9.9%
11
4.9%
1
1.2%
3
2.0%
9
10.1%
37
4.7%
13
4.6%
1009
6.5%
330
9.3%
 Caribbean453
3.8%
121
5.1%
162
5.2%
5
2.2%
1
1.2%
4
2.6%
4
4.5%
35
4,4%
1
0.4%
618
4.0%
168
4.7%
 South and Southeast Asia355
3.0%
39
1.6%
207
6.7%
9
4.0%
1
1.2%
6
4.0%
11
12.4%
27
3.4%
8
2.8%
436
2.8%
227
6.4%
 Other748
6.3%
149
6.3%
131
4.2%
39
17.4%
13
15.5%
9
6.0%
7
7.9%
75
9.4%
26
9.2%
1020
6.6%
177
5.0%
 Unknown46
0.4%
7
0.3%
9
0.3%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
5
0.6%
3
1.1%
58
0.4%
12
0.3%
Years aware of HIV infection
 <1473
4.0%
92
3.9%
87
2.8%
1
0.4%
0
0.0%
7
4.6%
0
0.0%
32
4.0%
7
2.5%
605
3.9%
94
2.6%
 1–21107
9.3%
211
8.9%
226
7.3%
2
0.9%
0
0.0%
8
5.3%
4
4.5%
75
9.4%
18
6.4%
1403
9.1%
248
7.0%
 3–41336
11.2%
224
9.4%
227
7.3%
2
0.9%
3
3.6%
14
9.3%
2
2.2%
65
8.2%
28
9.9%
1641
10.6%
260
7.3%
 5–103505
29.4%
624
26.3%
720
23.2%
18
8.0%
3
3.6%
21
13.9%
20
22.5%
191
24.0%
75
26.5%
4359
28.2%
818
23.0%
 10–203818
32.0%
1025
43.1%
1502
48.4%
85
37.9%
21
25.0%
48
31.8%
42
47.2%
321
40.4%
106
37.5%
5297
34.2%
1671
46.9%
 >201683
14.1%
197
8.3%
330
10.6%
116
51.8%
57
67.9%
51
33.8%
21
23.6%
99
12.5%
44
15.5%
2146
13.9%
452
12.7%
 Unknown6
0.1%
4
0.2%
12
0.4%
0
0.0%
0
0.0%
2
1.3%
0
0.0%
12
1.5%
5
1.8%
24
0.2%
17
0.5%
Current CD4 count in cells/mm3, median/IQR range
670
510–870
571
410–790
670
490–870
510
335–827
590
370–832
558
370–750
737
544–980
550
400–790
750
530–1050
650
480–854
680
490–880
Current CD8 count in cells/mm3, median/IQR range
860
640–1180
840
600–1177
770
573–1050
857
570–1200
886
671–1125
800
530–1100
890
635–1290
840
590–1170
740
480–1000
860
630–1180
780
573–1050
Current HIV RNA <200 copies/mL
 No503
4.2%
144
6.1%
209
6.7%
14
6.3%
7
8.3%
7
4.6%
8
9.0%
52
6.5%
24
8.5%
720
4.7%
282
7.9%
 Yes10 904
91.4%
2137
89.9%
2755
88.8%
193
86.2%
67
79.8%
140
92.7%
77
86.5%
689
86.7%
239
84.5%
14 063
90.9%
3217
90.4%
Current HIV RNA <100 copies/mL
 No605
5.1%
170
7.2%
243
7.8%
14
6.3%
5
6.0%
7
4.6%
7
7.9%
61
7.7%
23
8.1%
857
5.5%
244
6.9%
 Yes10 802
90.6%
2111
88.8%
2721
87.7%
193
86.2%
69
82.1%
140
92.7%
78
87.6%
680
85.5%
240
84.8%
13 926
90.0%
3142
88.2%
Ever AIDS
2125
17.8%
714
30.0%
676
21.8%
81
36.2%
35
41.7%
50
33.1%
24
27.0%
278
35.0%
81
28.6%
3248
21.0%
816
22.9%
AIDS at diagnosis
1129
9.5%
509
21.4%
395
12.7%
18
8.0%
6
7.1%
31
20.5%
12
13.5%
196
24.7%
43
15.2%
1883
12.2%
456
12.8%
Current HIV treatment
 Combination antiretroviral therapy11 642
97.6%
2307
97.1%
3013
97.1%
229
98.2%
84
100.0%
146
96.7%
89
100.0%
773
97.2%
278
98.2%
15 088
97.5%
3464
97.3%
 Currently not on combination antiretroviral therapy18
0.2%
2
0.1%
2
0.1%
0
0.0%
0
0.0%
0
0.0%
0
0.0%
1
0.1%
2
0.7%
21
0.1%
4
0.1%
 Not started268
2.2%
68
2.9%
89
2.9%
4
1.8%
0
0.0%
5
3.3%
0
0.0%
21
2.6%
3
1.1%
366
2.4%
92
2.6%
  • ATHENA, AIDS Therapy Evaluation in the Netherlands.